Vascular benefits of adding carvedilolCR to type2 diabetic patients on ACEI:effects on oxidative stress and inflammation

Trial Profile

Vascular benefits of adding carvedilolCR to type2 diabetic patients on ACEI:effects on oxidative stress and inflammation

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2012

At a glance

  • Drugs Carvedilol; Lisinopril
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 17 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Jun 2010 Planned end date changed from 1 May 2008 to 1 May 2013 as reported by ClinicalTrials.gov record.
    • 23 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top